Estimating influenza-related hospitalization in The Netherlands
- PMID: 9747764
- PMCID: PMC2809483
- DOI: 10.1017/s0950268898008966
Estimating influenza-related hospitalization in The Netherlands
Abstract
The purpose of this study was to examine the impact of influenza on hospitalization in The Netherlands. Two methods were applied to estimate this effect: (a) regression analysis and (b) comparison of hospitalization in epidemic years with non-epidemic years. Hospital discharge rates in 1984-93 have been considered. The study shows that, during the period studied, on average, almost 2700 people were hospitalized for influenza per annum, and that influenza was diagnosed as the main cause for hospitalization in only a fraction of these hospitalizations (326: 12%). From an economic perspective, these results imply that the cost-effectiveness of vaccination against influenza may be severely underestimated when looking only at changes achieved in the number of hospitalizations attributed to influenza.
Similar articles
-
Economic evaluation of influenza vaccination. Assessment for The Netherlands.Pharmacoeconomics. 1999;16 Suppl 1:33-40. doi: 10.2165/00019053-199916001-00005. Pharmacoeconomics. 1999. PMID: 10623374 Review.
-
Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.Vaccine. 2006 Nov 17;24(47-48):6812-22. doi: 10.1016/j.vaccine.2006.07.042. Epub 2006 Aug 4. Vaccine. 2006. PMID: 17034909
-
Modelling the health-economic impact of the next influenza pandemic in The Netherlands.Vaccine. 2006 Nov 10;24(44-46):6756-60. doi: 10.1016/j.vaccine.2006.05.065. Epub 2006 Jun 9. Vaccine. 2006. PMID: 16797797
-
Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78.Am J Public Health. 1986 Jul;76(7):761-5. doi: 10.2105/ajph.76.7.761. Am J Public Health. 1986. PMID: 3717461 Free PMC article.
-
Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.Vaccine. 2011 Oct 6;29(43):7554-8. doi: 10.1016/j.vaccine.2011.08.015. Epub 2011 Aug 4. Vaccine. 2011. PMID: 21820477 Review.
Cited by
-
The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality.Can J Public Health. 2003 Jan-Feb;94(1):59-63. doi: 10.1007/BF03405054. Can J Public Health. 2003. PMID: 12583681 Free PMC article.
-
Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence.Drugs Aging. 2000 Sep;17(3):217-27. doi: 10.2165/00002512-200017030-00005. Drugs Aging. 2000. PMID: 11043820 Review.
-
Economic evaluation of influenza vaccination. Assessment for The Netherlands.Pharmacoeconomics. 1999;16 Suppl 1:33-40. doi: 10.2165/00019053-199916001-00005. Pharmacoeconomics. 1999. PMID: 10623374 Review.
-
Factors associated with influenza vaccination coverage among the elderly in South Korea: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV).BMJ Open. 2016 Dec 28;6(12):e012618. doi: 10.1136/bmjopen-2016-012618. BMJ Open. 2016. PMID: 28031209 Free PMC article.
-
Pandemic influenza and healthcare demand in the Netherlands: scenario analysis.Emerg Infect Dis. 2003 May;9(5):531-8. doi: 10.3201/eid0905.020321. Emerg Infect Dis. 2003. PMID: 12737735 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical